Sort
48,018 grants matching “immunotherapy”
Reversing HIV T cell dysfunction by aptamer targeting of therapeutic siRNAs
$767,500Eli Gilboa · University Of Miami School Of Medicine · DP1 · FY2015 · DA
Reversing HIV T cell dysfunction by aptamer targeting of therapeutic siRNAs
$767,500Eli Gilboa · University Of Miami School Of Medicine · DP1 · FY2017 · DA
Reversing HIV T cell dysfunction by aptamer targeting of therapeutic siRNAs
$767,500Eli Gilboa · University Of Miami School Of Medicine · DP1 · FY2019 · DA
Complementary Adenoviral Vectors for Treatment of Cancer
$767,500Magnum Therapeutics · R44 · FY2005 · CA
Complementary Adenoviral Vectors for Treatment of Cancer
$767,500Magnum Therapeutics · R44 · FY2004 · CA
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
$767,423Paul John Norman · University Of Colorado Denver · R01 · FY2024 · AI
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
$767,423Paul John Norman · University Of Colorado Denver · R01 · FY2025 · AI
Targeting splicing vulnerability of neuroblastoma
$767,328Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2025 · CA
Dietary regulation of anti-tumor immunity through caloric restriction
$767,324Russell Jones · Van Andel Research Institute · U01 · FY2025 · CA
Clinical trials employing cancer vaccine combination therapies
$767,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$767,212James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
$767,167Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Assessing ADCC and Fc-mediated Protection against HIV
$767,088David T Evans · University Of Wisconsin-Madison · R01 · FY2023 · AI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$767,049James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2013 · DK
Evolution and Function of Immunogenetic Diversity across the Eastern Hemisphere
$766,987Paul John Norman · University Of Colorado Denver · R01 · FY2023 · AI
Mammalian and Plant-derived Antibody-based Therapies against Sudan Ebolavirus
$766,924John M Dye · Geneva Foundation · R01 · FY2016 · AI
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
$766,783David T Evans · University Of Wisconsin-Madison · R01 · FY2016 · AI
Developing new immunotherapies based of CD4+ T cells
$766,780Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$766,774Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2016 · CA
Targeting Blys/Baff in non-human primate islet transplantation
$766,318Ali Naji · University Of Pennsylvania · U01 · FY2015 · AI
A Multi-Institute Survivorship Study of Patients Living with Advanced Cancer Who Have Had Durable Response to Immune Checkpoint Inhibitors
$766,294Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Mechanisms of Clinical Reactivity or Tolerance to Mouse Allergen
$766,277Wayne G Shreffler · Massachusetts General Hospital · R01 · FY2012 · AI
Activated NK CAR Cells to Cure HIV
$766,149Pamela J Skinner · University Of Minnesota · R01 · FY2021 · AI
Mechanism of ARIA following Anti-Amyloid Immunotherapy
$766,133Akihiko Urayama · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AG
ATRX mutations, innate immune activation and therapeutic vulnerability in malignant gliomas
$766,065David M. Ashley · Duke University · R01 · FY2025 · CA